Stay updated on Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.

Latest updates to the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page
- ChecktodayChange DetectedAdded related topics Melanoma and MedlinePlus Genetics to the page, and removed the government funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check7 days agoChange DetectedThe Melanoma topic and the MedlinePlus Genetics related topics were removed from the page's related topics section.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedNo substantive changes detected between the two screenshots; the page still presents the Study Details for NCT01740297 with the same sections (Overview, Eligibility Criteria, Plan, Contacts and Locations).SummaryDifference0.3%

- Check36 days agoChange DetectedRemoved the MedlinePlus Genetics topic Melanoma from the page, reducing the page’s coverage of genetic topics related to melanoma.SummaryDifference0.1%

- Check43 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference2%

- Check50 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.0%

Stay in the know with updates to Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.